News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
105,875 Results
Type
Article (2988)
Company Profile (15)
Press Release (102872)
Section
Business (38863)
Career Advice (74)
Deals (7384)
Drug Delivery (7)
Drug Development (12754)
Employer Resources (7)
FDA (2128)
Job Trends (2458)
News (58806)
Policy (3562)
Tag
Academia (246)
Accelerated approval (7)
Allergies (47)
Alliances (4190)
ALS (32)
Alzheimer's disease (275)
Antibody-drug conjugate (ADC) (61)
Approvals (2278)
Artificial intelligence (42)
Autoimmune disease (38)
Automation (5)
Bankruptcy (22)
Best Places to Work (2289)
BIOSECURE Act (1)
Biosimilars (16)
Biotechnology (8)
Bladder cancer (56)
Brain cancer (8)
Breast cancer (129)
Cancer (1088)
Cardiovascular disease (84)
Career advice (70)
Career pathing (2)
CAR-T (39)
Cell therapy (116)
Cervical cancer (10)
Clinical research (12074)
Collaboration (184)
Company closure (1)
Compensation (140)
Complete response letters (5)
COVID-19 (261)
CRISPR (8)
C-suite (46)
Cystic fibrosis (19)
Data (1700)
Depression (33)
Dermatology (10)
Diabetes (58)
Diagnostics (1075)
Digital health (6)
Diversity, equity & inclusion (2)
Drug discovery (26)
Drug pricing (7)
Duchenne muscular dystrophy (36)
Earnings (34128)
Editorial (3)
Employer branding (1)
Employer resources (6)
Events (14731)
Executive appointments (59)
FDA (2907)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (3)
Frontotemporal dementia (12)
Funding (183)
Gene editing (17)
Generative AI (4)
Gene therapy (94)
GLP-1 (158)
Government (474)
Grass and pollen (2)
Guidances (292)
Healthcare (3158)
HIV (18)
Huntington's disease (13)
IgA nephropathy (27)
Immunology and inflammation (55)
Immuno-oncology (13)
Indications (37)
Infectious disease (313)
Inflammatory bowel disease (40)
Influenza (19)
Intellectual property (26)
Interviews (8)
IPO (5481)
IRA (3)
Job creations (303)
Job search strategy (63)
JPM (5)
Kidney cancer (9)
Labor market (12)
Layoffs (47)
Leadership (2)
Legal (480)
Liver cancer (17)
Longevity (3)
Lung cancer (184)
Lymphoma (133)
Machine learning (4)
Management (2)
Manufacturing (74)
MASH (56)
Medical device (2460)
Medtech (2469)
Mergers & acquisitions (2167)
Metabolic disorders (213)
mRNA (7)
Multiple sclerosis (27)
NASH (5)
Neurodegenerative disease (63)
Neuropsychiatric disorders (16)
Neuroscience (498)
NextGen: Class of 2026 (782)
Non-profit (472)
Now hiring (3)
Obesity (87)
Opinion (15)
Ovarian cancer (39)
Pain (26)
Pancreatic cancer (41)
Parkinson's disease (52)
Partnered (2)
Patents (46)
Patient recruitment (63)
Peanut (14)
People (3519)
Pharmaceutical (7)
Pharmacy benefit managers (3)
Phase 1 (3160)
Phase 2 (5025)
Phase 3 (4866)
Pipeline (2497)
Policy (19)
Postmarket research (437)
Preclinical (912)
Press Release (4)
Prostate cancer (52)
Psychedelics (1)
Radiopharmaceuticals (45)
Rare diseases (180)
Real estate (436)
Recruiting (3)
Regulatory (3308)
Reports (20)
Research institute (213)
Resumes & cover letters (6)
Rett syndrome (9)
RNA editing (3)
RSV (13)
Schizophrenia (33)
Series A (28)
Series B (22)
Sickle cell disease (18)
Special edition (3)
Spinal muscular atrophy (11)
Sponsored (2)
Startups (249)
Stomach cancer (1)
Supply chain (12)
Tariffs (1)
The Weekly (2)
Vaccines (153)
Venture capital (11)
Weight loss (55)
Women's health (16)
Worklife (1)
Date
Today (13)
Last 7 days (149)
Last 30 days (661)
Last 365 days (6294)
2026 (1620)
2025 (6380)
2024 (7453)
2023 (8411)
2022 (10606)
2021 (10234)
2020 (8940)
2019 (6899)
2018 (5200)
2017 (5058)
2016 (4038)
2015 (5130)
2014 (3358)
2013 (2298)
2012 (2474)
2011 (2711)
2010 (2790)
Location
Africa (60)
Alabama (10)
Arizona (42)
Arkansas (2)
Asia (5690)
Australia (1047)
California (2424)
Canada (660)
China (176)
Colorado (141)
Connecticut (96)
Delaware (112)
Europe (20307)
Florida (333)
Georgia (92)
Hawaii (1)
Idaho (4)
Illinois (164)
India (8)
Indiana (131)
Iowa (3)
Japan (162)
Kansas (21)
Kentucky (7)
Louisiana (17)
Maine (20)
Maryland (301)
Massachusetts (1790)
Michigan (71)
Minnesota (155)
Missouri (19)
Montana (5)
Nebraska (3)
Nevada (29)
New Hampshire (13)
New Jersey (798)
New Mexico (1)
New York (762)
North Carolina (275)
North Dakota (2)
Northern California (1353)
Ohio (46)
Oklahoma (1)
Oregon (3)
Pennsylvania (494)
Puerto Rico (1)
Rhode Island (1)
South America (132)
South Carolina (5)
Southern California (915)
Tennessee (30)
Texas (334)
United States (8781)
Utah (62)
Virginia (38)
Washington D.C. (8)
Washington State (183)
Wisconsin (20)
105,875 Results for "33".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ablexis Reports 33 AlivaMab(R) Mouse-Derived Human Antibodies Now in Clinical Development, Further Validating AlivaMab Mouse Transgenic Platform
March 4, 2026
·
2 min read
Press Releases
ImmunityBio Receives Authorization from the European Commission for ANKTIVA® with BCG for Non-Muscle Invasive Bladder Cancer Carcinoma in Situ, Expanding Global Access to 33 Countries
February 18, 2026
·
14 min read
Press Releases
Juvena Therapeutics Raises $33.5M Series B Led by Bison Ventures to Advance Regenerative Biologics Pipeline
January 13, 2026
·
3 min read
Press Releases
ImmunityBio Reports 700% Year-Over-Year Revenue Growth, Expanded ANKTIVA® Approvals in Lung Cancer and Global Commercial Partnerships in 33 Countries with Label Expansion Plans Globally
February 23, 2026
·
19 min read
Press Releases
EpilepsyGTx Raises $33 Million Series A to Develop Single Dose Gene Therapy for Focal Refractory Epilepsy
December 11, 2025
·
3 min read
Press Releases
Aperture Therapeutics Announces Development Candidate Targeting CD33 to Restore Microglial Homeostasis in FTD and ALS
November 20, 2025
·
2 min read
Press Releases
Locus Biosciences Awarded $3.3 Million from NIH to Support Clinical Trial of AI-Designed Bacteriophage Therapy for Pneumonia caused by Antibiotic Resistant Bacteria
January 8, 2026
·
3 min read
Press Releases
Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million
December 8, 2025
·
6 min read
Venture capital
Early-Stage Biotechs Suffer in 2025 As VC Shuns Risk: PitchBook
PitchBook’s 2025 biopharma VC analysis clocked $33.8 billion in capital dispatched in 2025, mainly to companies with later-stage programs ready to roll into the clinic.
February 18, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Point of Care Testing (POCT) Market Size Worth USD 125.33 Bn by 2034 Amid Growing Adoption of Rapid and AI-Enabled Diagnostic Technologies
December 1, 2025
·
1 min read
1 of 10,588
Next
